lorlatinib [Supplementary Concept]
inhibits both anaplastic lymphoma kinase and c-ros oncogene 1 (ROS1) protein
Date introduced: August 17, 2014
PubMed search builder options
MeSH Unique ID: C000590786
Registry Number: OSP71S83EU
Heading Mapped to:
Entry Terms:
- (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-H)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile
- loratinib
- 7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile
- PF-06463922
- PF06463922
- Lorbrena